Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fundación Jacinto Convit is a non-profit biotechnology and research organization based in Venezuela, dedicated to advancing the scientific legacy of Dr. Jacinto Convit. The foundation focuses on developing accessible, low-cost immunotherapies for cancer and infectious diseases, most notably through its ConvitVax platform, an autologous immunotherapy for breast cancer. In addition to its therapeutic pipeline, the foundation operates a robust molecular diagnostics program providing specialized testing for pediatric oncology and infectious diseases. By combining high-level R&D with a humanitarian mission, the foundation aims to bridge the gap between advanced medical science and underserved populations in Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fundación Jacinto Convit.